Synta Pharmaceuticals, Inc. (NASDAQ: SNTA) filed a registration with the U.S. SEC to sell, from time to time, up to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE